Gene · 1031
Papers2,553
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,553
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell profiling of multiple myeloma reveals molecular response to FGFR3 inhibitor despite clinical progression. | Cold Spring Harb Mol Case Stud | 2023 | 36639200 | PubTator, text mining | PubMed |
| Genomic Profiling Reveals the Variant Landscape of Sporadic Parathyroid Adenomas in Chinese Population. | J Clin Endocrinol Metab | 2023 | 36611251 | PubTator, text mining | PubMed |
| Genomic Alterations and Tumor Mutation Burden in Merkel Cell Carcinoma. | JAMA Netw Open | 2023 | 36602798 | PubTator, text mining | PubMed |
| High throughput sequencing revealed enhanced cell cycle signaling in SLE patients. | Sci Rep | 2023 | 36599883 | PubTator, text mining | PubMed |
| AGA induces sub-G1 cell cycle arrest and apoptosis in human colon cancer cells through p53-independent/p53-dependent pathway. | BMC Cancer | 2023 | 36597025 | PubTator, text mining | PubMed |
| Cannabidiol-induced transcriptomic changes and cellular senescence in human Sertoli cells. | Toxicol Sci | 2023 | 36519830 | PubTator, text mining | PubMed |
| Mutant NPM1 Directly Regulates Oncogenic Transcription in Acute Myeloid Leukemia. | Cancer Discov | 2023 | 36455613 | PubTator, text mining | PubMed |
| Amp(1q) and tetraploidy are commonly acquired chromosomal abnormalities in relapsed multiple myeloma. | Eur J Haematol | 2023 | 36433728 | PubTator, text mining | PubMed |
| Novel germline variants of CDKN1B and CDKN2C identified during screening for familial primary hyperparathyroidism. | J Endocrinol Invest | 2023 | 36334246 | PubTator, text mining | PubMed |
| Waldenström macroglobulinemia whole genome reveals prolonged germinal center activity and late copy number aberrations. | Blood Adv | 2023 | 36332058 | PubTator, text mining | PubMed |
| BMI-1 promotes breast cancer proliferation and metastasis through different mechanisms in different subtypes. | Cancer Sci | 2023 | 36285479 | PubTator, text mining | PubMed |
| A Molecular Switch between Mammalian MLL Complexes Dictates Response to Menin-MLL Inhibition. | Cancer Discov | 2023 | 36264143 | PubTator, text mining | PubMed |
| Molecular hallmarks of long non-coding RNAs in aging and its significant effect on aging-associated diseases. | Neural Regen Res | 2023 | 36254975 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| miR-31/QKI-5 axis facilitates cell cycle progression of non-small-cell lung cancer cells by interacting and regulating p21 and CDK4/6 expressions. | Cancer Med | 2023 | 36172919 | PubTator, text mining | PubMed |
| Small extracellular vesicles secreted by induced pluripotent stem cell-derived mesenchymal stem cells improve postoperative cognitive dysfunction in mice with diabetes. | Neural Regen Res | 2023 | 36018185 | PubTator, text mining | PubMed |
| SUMOylation inhibition overcomes proteasome inhibitor resistance in multiple myeloma. | Blood Adv | 2023 | 35917568 | PubTator, text mining | PubMed |
| Anaplastic multiple myeloma with amplification of the IGH-CCND1 gene fusion. | Hematol Transfus Cell Ther | 2023 | 34862156 | PubTator, text mining | PubMed |
| Cytogenetic Abnormalities in Multiple Myeloma: Incidence, Prognostic Significance, and Geographic Heterogeneity in Indian and Western Populations. | Cytogenet Genome Res | 2022 | 36780889 | PubTator, text mining | PubMed |
| [Case of clinically "aggressive" course of primary hyperparathyroidism, algorithm of differential diagnosis]. | Probl Endokrinol (Mosk) | 2022 | 36689712 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1031/papers?page=13